Analyst Price Target is $242.40
▲ +19.27% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for STERIS in the last 3 months. The average price target is $242.40, with a high forecast of $275.00 and a low forecast of $210.00. The average price target represents a 19.27% upside from the last price of $203.23.
Current Consensus is
The current consensus among 5 contributing investment analysts is to buy stock in STERIS. This Buy consensus rating has held steady for over two years.
STERIS Plc engages in the provision of healthcare and life science product and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment provides a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Mentor, OH.